Loading insider details...
Beta
Latest Form 4 (Mar 4, 2026): Disposition to Issuer of 145,000 VTYX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 4, 2026 | Ventyx Biosciences, Inc. (VTYX) | Disposition to Issuer | 145,000 | n/a |
| Jan 3, 2025 | Ventyx Biosciences, Inc. (VTYX) | Grant/Award | 145,000 | n/a |
| May 17, 2024 | Ventyx Biosciences, Inc. (VTYX) | Grant/Award | 320,000 | n/a |
| May 3, 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 4,166 | n/a |
| Mar 6, 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 3,468 | $38.6K |
| Feb 15, 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 26,666 | n/a |
| Jan 17, 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 28,000 | n/a |
| Sep 12, 2023 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 12,500 | n/a |
| Mar 6, 2023 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 1,589 | $25.1K |
| Mar 8, 2022 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 13,300 | n/a |